Elanco Animal Health Incorporated

$25.00 3.78%(+$0.91)
TickerSpark Score
65/100
Solid
80
Valuation
35
Profitability
35
Growth
76
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELAN research report →

52-Week Range81% of range
Low
$13.39
Current
$25.00
High
$27.72
Company Overviewwww.elanco.com

About the company

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro.

CEO
Jeffrey N. Simmons
IPO
2018
Employees
9,000
HQ
Greenfield, IN, US

Price Chart

+69.84% · this period
$26.84$20.26$13.68Jul 02Dec 31Jul 02
Valuation
Market Cap
$12.49B
P/E
-50.22
P/S
2.55
P/B
1.91
EV/EBITDA
21.01
Div Yield
0.00%
Profitability
Gross Margin
49.44%
Op Margin
8.95%
Net Margin
-4.95%
ROE
-3.64%
ROIC
3.77%
Growth & Income
Revenue
$4.71B · 6.22%
Net Income
$-232,000,000 · -168.64%
EPS
$-0.47 · -169.12%
Op Income
$252.00M
FCF YoY
-27.92%
Performance & Tape
52W High
$27.72
52W Low
$13.39
50D MA
$23.13
200D MA
$22.88
Beta
1.70
Avg Volume
5.80M

Get TickerSpark's AI analysis on ELAN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 1, 26Kinard David Sother25,620
Jun 30, 26Anand Kapila Kother584.112
Jun 26, 26Modi Rajeev A.other60.111
Jun 26, 26Simmons Jeffrey Nother115.056
Jun 26, 26VanHimbergen Robert Mother8.019
Jun 12, 26VanHimbergen Robert Mother8.151
Jun 12, 26Simmons Jeffrey Nother116.96
Jun 12, 26Modi Rajeev A.other61.106
May 29, 26VanHimbergen Robert Mother8.261
May 29, 26Modi Rajeev A.other61.926
Coverage · ELAN

Our ELAN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ELAN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ELAN report →
Internal Compare

Similar companies

Peers in the same neighborhood.